Moleculin Biotech (MBRX) Intangibles (2020 - 2025)
Moleculin Biotech (MBRX) posted quarterly Intangibles of $11.1 million for Q4 2025, little changed year-over-year from $11.1 million in Q4 2024, and little changed quarter-over-quarter from $11.1 million in Q4 2024.
Moleculin Biotech (MBRX) Intangibles (2020 - 2025) Analysis & Trends
Moleculin Biotech's Intangibles history runs 6 years deep, the most recent figure standing at $11.1 million for Q4 2025.
- In Q4 2025, Intangibles changed 0.0% year-over-year to $11.1 million; the TTM figure through Dec 2025 stood at $11.1 million (changed 0.0% YoY), while the FY2025 annual figure was $11.1 million, changed 0.0% from the prior year.
- Intangibles for Q4 2025 stood at $11.1 million, roughly flat from $11.1 million in the prior quarter.
- The five-year high for Intangibles was $11.1 million in Q4 2021, with the low at $11.1 million in Q4 2021.
- The 5-year median for Intangibles is $11.1 million (2021), against an average of $11.1 million.
- Peak annual rise in Intangibles reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
- Moleculin Biotech's Intangibles stood at $11.1 million in 2021, then changed by 0.0% to $11.1 million in 2022, then changed by 0.0% to $11.1 million in 2023, then changed by 0.0% to $11.1 million in 2024, then changed by 0.0% to $11.1 million in 2025.
- Business Quant data shows MBRX's Intangibles at $11.1 million in Q4 2025, $11.1 million in Q4 2024, and $11.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 93.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Moleculin Biotech | 3.35 Mn | 3.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 11.10 Mn |
| Dec 31, 2023 | 11.10 Mn |
| Dec 31, 2022 | 11.10 Mn |
| Dec 31, 2021 | 11.10 Mn |
| Dec 31, 2020 | 11.10 Mn |